SCHEMBL6975288

SCHEMBL6975288

NC(=O)CCN1CC[C@H](NC(=O)[C@@H]2CCCCN2c2nc3ccccc3o2)C1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.48
TSHR P16473 4/20 0.48
MAPT P10636 4/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
HTT P42858 2/20 0.48
ELANE P08246 2/20 0.43
ALDH1A1 P00352 5/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
OPRK1 P41145 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
HCRTR1 O43613 1/20 0.38
HCRTR2 O43614 1/20 0.38
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
CHRNA7 P36544 1/20 0.37
HTR3A P46098 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6966984 0.91 LMNA (0.50) LMNATSHRMAPTSMN1; SMN2HTT
SCHEMBL6968264 0.86 OPRK1 (0.56) LMNATSHRMAPTSMN1; SMN2HTT
SCHEMBL6978779 0.86 OPRK1 (0.56) LMNATSHRMAPTSMN1; SMN2HTT
SCHEMBL6975553 0.86 LMNA (0.49) LMNATSHRMAPTSMN1; SMN2HTT
SCHEMBL6975047 0.84 OPRK1 (0.48) LMNATSHRMAPTSMN1; SMN2HTT
SCHEMBL6974109 0.84 LMNA (0.53) LMNATSHRMAPTSMN1; SMN2HTT
SCHEMBL6975195 0.84 LMNA (0.45) LMNATSHRMAPTSMN1; SMN2HTT
SCHEMBL7083455 0.83 LMNA (0.47) LMNATSHRMAPTSMN1; SMN2HTT
SCHEMBL6975899 0.83 LMNA (0.49) LMNATSHRMAPTSMN1; SMN2HTT
Hydrochloric Acid SCHEMBL7658654 0.83 LMNA (0.44) LMNATSHRMAPTSMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6562964-B1 Inhibitors of rotamase enzymes in particular FKBP-12 and FKBP-52. The compounds therefore moderate neuronal regeneration and outgrowth and can be used for treating neurological disorders arising from neurodegenerative diseases or other disorders PFIZER INC 2003-05-13 US disclosed
EP-1100797-B1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ROTAMASE ENZYMES PFIZER LTD (GB) 2003-02-26 EP disclosed
US-6372736-B1 ENZYME INHIBITORS PFIZER INC 2002-04-16 US disclosed